<DOC>
	<DOC>NCT02862600</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of perhexiline on exercise performance (efficacy) and safety in patients with hypertrophic cardiomyopathy and moderate-to-severe heart failure following dosing for 16 weeks.</brief_summary>
	<brief_title>Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy, Hypertrophic</mesh_term>
	<mesh_term>Cardiomyopathy, Hypertrophic, Familial</mesh_term>
	<mesh_term>Perhexiline</mesh_term>
	<criteria>Key Hypertrophic cardiomyopathy with symptoms of moderatetosevere heart failure Left ventricular hypertrophy with maximum LV wall thickness ≥ 15 mm Left ventricular ejection fraction ≥ 50% Able to perform exercise testing but unable to exceed 75% of the predicted ageadjusted maximum level Key CYP2D6 Poor Metabolizer (PM) status History of a known chronic liver disease ALT, AST, alkaline phosphatase, or LDH &gt; 1.5 x upper limit of normal Total Bilirubin &gt; 2.0 x upper limit of normal Severe LV outflow obstruction Asymptomatic patients or cardiomyopathyrelated criteria as per protocol QT interval related criteria as per protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>hypertrophic cardiomyopathy</keyword>
	<keyword>hypertrophic</keyword>
	<keyword>cardiomyopathy</keyword>
	<keyword>familial hypertrophic cardiomyopathy</keyword>
	<keyword>heart failure</keyword>
	<keyword>cardiopulmonary exercise testing</keyword>
	<keyword>6 minute walk test</keyword>
	<keyword>perhexiline</keyword>
	<keyword>carnitine palmitoyltransferase</keyword>
	<keyword>carbohydrate utilization</keyword>
	<keyword>coronary ischemia</keyword>
	<keyword>angina</keyword>
	<keyword>mixed ion channel effects</keyword>
	<keyword>late sodium current inhibitor</keyword>
	<keyword>calcium channel inhibition</keyword>
</DOC>